Skip to content

Charger MMT-7715

by Medtronic Minimed, Inc.

Ref MMT-7715

Charger MMT-7715 is a medical device (EU MDR Class I; FDA Class III; FDA product code OZP, Automated insulin dosing device system, single hormonal control) made by Medtronic Minimed, Inc., registered in EUDAMED on 6 Jul 2026 (Basic UDI-DI 0763000B00000336V), approved under FDA PMA P160007 on 8 Mar 2018 (1 earlier submission) and listed in FDA GUDID since 20 Feb 2022 (UDI-DI 00763000347659), active as of 23 Oct 2026.

Active European Union and United States. Also listed in GUDID (US).

CE MDR PMA

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

3 ongoing

Recall on shared PMA P120010, P160007; other models may be affected

Documents

None linked in EUDAMED

A group certificate may exist

PMA P160007

+1 more

Trust

Unverified

Source EUDAMED, GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR EUDAMED Number0763000B00000336V Basic UDI-DI 00763000347659UDI-DIDate6 Jul 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00763000347659 UDI-DI Date20 Feb 2022ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR GUDID from GUDID Approved NumberP160007 Date8 Mar 2018DecidedStatusActive

Official records

From the FDA record

Device description
CHARGER MMT-7715 MDR 21L IIN TR
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 0763000B00000336V registered 6 Jul 2026 Active
  • FDA PMA P160007 decided 8 Mar 2018 Active· +1 more in the status table
  • FDA GUDID UDI-DI 00763000347659 listed 20 Feb 2022 Listed

Recalls

5 recalls · 3 ongoing · FDA

    • Ongoing Z-1751-2026 FDA Class II initiated 13 Feb 2026 on shared PMA P120010

    All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

    • Ongoing Z-0033-2026 FDA Class II initiated 7 May 2025 on shared PMA P160007

    The device cap label may not adhere to the sensor, compromising the sterility of the sensor, and increasing the risk of infection.

    • Ongoing Z-2106-2020 FDA Class II initiated 20 May 2019 on shared PMA P160007

    Customers using the firm's continuous glucose monitoring system application on an iPhone, iPad or iPod Touch with ios software version 12, 12.1, or 12,2 are likely to experience a shortened transmitter battery life (approximately 4-5 days instead of the normal 7 days or more) after a full charge.

    • Terminated Z-1282-2019 FDA Class II initiated 4 Jul 2018 on shared PMA P160007

    The application may be closed by the operating system without alerting the user the app is no longer running or communicating with the transmitter resulting in the user not receiving alerts that could be associated with hypoglycemic or hyperglycemic events.

    • Terminated Z-2544-2014 FDA Class II initiated 13 Mar 2014 on shared PMA P120010

    Medtronic is recalling the Medtronic MiniMed Paradigm Insulin Infusion Pumps because they have received reports that users have accidentally programmed the pump to deliver the maximum bolus amount.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

9 dated events

  1. Approved FDA PMA P120010
  2. Recall initiated FDA recalls Z-2544-2014
  3. Approved FDA PMA P160007
  4. Recall initiated FDA recalls Z-1282-2019
  5. Recall initiated FDA recalls Z-2106-2020
  6. Listed FDA GUDID 00763000347659
  7. Recall initiated FDA recalls Z-0033-2026
  8. Recall initiated FDA recalls Z-1751-2026
  9. Registered EUDAMED 0763000B00000336V

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA PMA Active

Specification

EUDAMED · GUDID

Trade name
Charger
Generic name
Percutaneous interstitial fluid glucose monitoring system, electrochemical
Device name
Battery Charger (MiniMed Gray Charger)
Model / reference
MMT-7715
Primary DI / UDI-DI
00763000347659
Basic UDI-DI
0763000B00000336V
FDA product code
OZP
EMDN code
Z12040180 General medicine diagnosis and monitoring instruments - hardware accessories
GMDN term
Percutaneous interstitial fluid glucose monitoring system, electrochemical
Device class
Class I EUDAMED
Class III GUDID
EU registration type
Standard device
EU market of registration
Netherlands
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class I
GUDID
Class III

Device class is stated on each registry's own scale: Class I in the EU (EUDAMED), Class III in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under GENERAL MEDICINE DIAGNOSIS AND MONITORING INSTRUMENTS.

Other devices from Medtronic Minimed, Inc.

See all devices from Medtronic Minimed, Inc. →

Properties

  • Prescription use
  • Lot / batch number
Other properties (23, all answered No)